Innovative Import Substitution: Potential Paths for Sovereign Technological Development

18 Jun , 10:00–11:15
Modern Technology for Humanity: Building a Responsible Future
Congress Centre, conference hall B2

In the long term, Russia might not just substitute imports as a way to replace certain foreign products, but also to replace technologies with advanced domestic ones. In order to implement this strategy, however, it is essential to identify the needs of business for real technology and relay them to universities and scientific organizations. Medium-sized technology companies that are able to implement early Deep Tech projects also need to be involved in collaboration between science and big business. In addition, to achieve results more quickly, clear management signals and support measures for both science and business are needed from the federal and regional authorities. To what extent are Russian scientific organizations and technology businesses ready to accelerate import substitution? What needs to change in the infrastructure used to transfer technology from science to business? How can Russian businesses follow the trends on the global innovation market in the current conditions? How can Russian science help to fill in the lost links of the chains of global cooperation? How can the opportunities offered by the regions be effectively put to use for import substitution? What support measures are needed to replace technology imports?

Aleksey Filimonov, Executive Director of the National Association for Technology Transfer

Alexei Beloshitsky, Executive Director, Competence Center of NTI in the Field of "Technologies for storage and analysis of big data", Lomonosov Moscow State University
Alexey Vashkevich, Director of the Directorate for Technological Development, Gazprom Neft
Anton Kurylenko, General Director, Gazprom CPS
Oleg Neretin, Director, Federal Institute of Industrial Property
Natalya Popova, First Deputy General Director, Innopraktika
Vadim Tarasov, Director, Institute of Translational Medicine and Biotechnology Institute of Translational Medicine and Biotechnology, First Moscow State Medical University named after I.M. Sechenov